Colorectal cancer is the second leading cause of cancer death in the U.S., but new research on regular aspirin use shows promise in lowering your risk of the disease. The study followed more than 10,000 adults who took aspirin regularly and compared them to those who did not. Research showed that aspirin had a positive response on those who took it, however those with less-healthy, sedentary lifestyles benefited the most. A daily low-dose (81 mg.) of aspirin had the best outcomes and worked best to lower the risk of developing colorectal cancer. Learn more about aspirin and colon cancer.
Home Newsletters Hide from Home Page Health Tip of the Week, sponsored by Baton Rouge General: Can an...
GET DAILY REPORT FREE

